Search

Rigel Pharmaceuticals Inc

Отворен

СекторЗдравеопазване

36.76 -3.54

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

36.66

Максимум

38.11

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+55.89% upside

Дивиденти

By Acuity

Следващи печалби

4.08.2026 г.

Настроения в новините

By Acuity

50%

50%

162 / 340 Класиране в Healthcare

Rigel Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.07.2026 г., 19:29 ч. UTC

Rigel Pharmaceuticals Inc shares are lower today amid unusual volatility, reaching a session low earlier after peaking shortly after the market opened.

29.07.2026 г., 19:47 ч. UTC

Rigel Pharmaceuticals Inc. is trading higher Wednesday, pulling back from earlier session highs amid mixed performance across major U.S. indices ahead of the Fed's decision.

28.07.2026 г., 19:56 ч. UTC

News

Rigel Pharmaceuticals shares are higher today as the company announced a conference call for its second quarter 2026 financial results on August 4.

27.07.2026 г., 16:16 ч. UTC

Rigel Pharmaceuticals is higher during Monday's session, rebounding after six days of declines. The stock remains up since Friday's close amid broader market dynamics.

24.07.2026 г., 20:01 ч. UTC

Rigel Pharmaceuticals Inc shares are higher today, recovering from earlier dips amid increased trading volume and broader market gains despite no specific news identified.

22.07.2026 г., 20:06 ч. UTC

Rigel Pharmaceuticals Inc shares are lower Wednesday amid ongoing market uncertainty ahead of the Federal Reserve meeting, with no specific news driving the decline.

21.07.2026 г., 17:26 ч. UTC

News

Rigel Pharmaceuticals Inc shares are higher, reflecting positive sentiment in the biotechnology sector amid broader market gains, particularly in technology stocks.

Сравнение с други в отрасъла

Ценова промяна

Rigel Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

55.89% нагоре

12-месечна прогноза

Среден 59.33 USD  55.89%

Висок 81 USD

Нисък 40 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Rigel Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

2

Купи

1

Задържане

0

Продай

Настроение

By Acuity

162 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

$

help-icon Live chat